The Global Fund is a worldwide partnership to defeat HIV, TB and malaria and ensure a healthier, safer, and more equitable future for all, in partnership with governments, civil society, technical agencies, the private sector and people affected by the diseases. Since the Global Fund returned to Myanmar in 2009, UNOPS Asia Regional Health Cluster (ARHC) has been named one of two Principal Recipients (PR) of Global Fund grants, together with Save the Children.
As a Principal Recipient, UNOPS ARHC is responsible for delivering the targets in the grant agreement in collaboration with selected Sub-Recipients (SRs) from the national programmes, international and local non-governmental organizations (NGOs), and United Nations agencies.
UNOPS ARHC has assisted in managing US$768.2 million worth of Global Fund grants from 2011 to 2023 to provide better access to the prevention, care and treatment for HIV, TB and malaria. UNOPS was again selected as a Principal Recipient (PR) to manage the new funding of US$170 million for the continuation of HIV, TB and malaria programme implementation in Myanmar over the next three-year period (2024-2026). The grants from the Global Fund have allowed those most in need to better access prevention, care and treatment for HIV, TB and malaria.
UNOPS was also selected as the Regional Principal Recipient for the Regional Artemisinin-resistance Initiative (RAI), which aims to escalate progress towards eliminating malaria in Cambodia, Lao PDR, Myanmar, Thailand and Viet Nam. The RAI is expended for three years (2024-2026) under the fourth phase, the RAI4-Elimination (RAI4E) with the grant approval value of US$146.3 million.
